Journal of NeuroVirology

, Volume 11, Issue 1, pp 1–10 | Cite as

Autistic disorder and viral infections

  • Jane E. Libbey
  • Thayne L. Sweeten
  • William M. McMahon
  • Robert S. Fujinami
Review

Abstract

Autistic disorder (autism) is a behaviorally defined developmental disorder with a wide range of behaviors. Although the etiology of autism is unknown, data suggest that autism results from multiple etiologies with both genetic and environmental contributions, which may explain the spectrum of behaviors seen in this disorder. One proposed etiology for autism is viral infection very early in development. The mechanism, by which viral infection may lead to autism, be it through direct infection of the central nervous system (CNS), through infection elsewhere in the body acting as a trigger for disease in the CNS, through alteration of the immune response of the mother or offspring, or through a combination of these, is not yet known. Animal models in which early viral infection results in behavioral changes later in life include the influenza virus model in pregnant mice and the Borna disease virus model in newborn Lewis rats. Many studies over the years have presented evidence both for and against the association of autism with various viral infections. The best association to date has been made between congenital rubella and autism; however, members of the herpes virus family may also have a role in autism. Recently, controversy has arisen as to the involvement of measles virus and/or the measles, mumps, rubella (MMR) vaccine in the development of autism. Biological assays lend support to the association between measles virus or MMR and autism whereas epidemiologic studies show no association between MMR and autism. Further research is needed to clarify both the mechanisms whereby viral infection early in development may lead to autism and the possible involvement of the MMR vaccine in the development of autism.

Keywords

autism immune response virus virus infection 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams JM, Imagawa DT (1962). Measles antibodies in multiple sclerosis. Proc Soc Exp Biol Med 111: 562–566.PubMedGoogle Scholar
  2. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders, 4th (DSM-IV) edition. Washington, DC: American Psychiatric Association.Google Scholar
  3. Anlar B, Oktem F, Torok T (1994). Human parvovirus B19 antibodies in infantile autism. J Child Neurol 9: 104–105.PubMedCrossRefGoogle Scholar
  4. Araujo DM, Lapchak PA, Collier B, Quirion R (1989). Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Res 498: 257–266.PubMedCrossRefGoogle Scholar
  5. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, Rutter M (1995). Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 25: 63–77.PubMedCrossRefGoogle Scholar
  6. Barak Y, Kimhi R, Stein D, Gutman J, Weizman A (1999). Autistic subjects with comorbid epilepsy: a possible association with viral infections. Child Psychiatry Hum Dev 29: 245–251.PubMedCrossRefGoogle Scholar
  7. Bartlik BD (1981). Monthly variation in births of autistic children in North Carolina. J Am Med Womens Assoc 36: 363–368.PubMedGoogle Scholar
  8. Blattner RJ (1974). The role of viruses in congenital defects. Am J Dis Child 128: 781–786.PubMedGoogle Scholar
  9. Chakrabarti S, Fombonne E (2001). Pervasive developmental disorders in preschool children. JAMA 285: 3093–3099.PubMedCrossRefGoogle Scholar
  10. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M (1995). Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 92: 7440–7444.PubMedCrossRefGoogle Scholar
  11. Chess S (1971). Autism in children with congenital rubella. J Autism Child Schizophr 1: 33–47.PubMedCrossRefGoogle Scholar
  12. Chess S (1977). Follow-up report on autism in congenital rubella. J Autism Child Schizophr 7: 69–81.PubMedCrossRefGoogle Scholar
  13. Ciaranello AL, Ciaranello RD (1995). The neurobiology of infantile autism. Annu Rev Neurosci 18: 101–128.PubMedCrossRefGoogle Scholar
  14. Coleman M, Gillberg C (1985). The biology of the autistic syndromes. New York: Praeger Publishers.Google Scholar
  15. Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN (1999). Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 14: 388–394.PubMedCrossRefGoogle Scholar
  16. Connolly AM, Chez MG, Pestronk A, Arnold ST, Mehta S, Deuel RK (1999). Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J Pediatr 134: 607–613.PubMedCrossRefGoogle Scholar
  17. Cook EH Jr (2001). Genetics of autism. Child Adolesc Psychiatr Clin N Am 10: 333–350.PubMedGoogle Scholar
  18. Croen LA, Grether JK, Hoogstrate J, Selvin S (2002). The changing prevalence of autism in California. J Autism Dev Disord 32: 207–215.PubMedCrossRefGoogle Scholar
  19. Dales L, Hammer SJ, Smith NJ (2001). Time trends in autism and in MMR immunization coverage in California. JAMA 285: 1183–1185.PubMedCrossRefGoogle Scholar
  20. Dalod M, Salazar-Mather TP, Malmgaard L, Lewis C, Asselin-Paturel C, Briere F, Trinchieri G, Biron CA (2002). Interferon α/β and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J Exp Med 195: 517–528.PubMedCrossRefGoogle Scholar
  21. Dalton P, Deacon R, Blamire A, Pike M, McKinlay I, Stein J, Styles P, Vincent A (2003). Maternal neuronal antibodies associated with autism and a language disorder. Ann Neurol 53: 533–537.PubMedCrossRefGoogle Scholar
  22. De Long GR, Bean SC, Brown FR III (1981). Acquired reversible autistic syndrome in acute encephalopathic illness in children. Arch Neurol 38: 191–194.Google Scholar
  23. Desmond MM, Wilson GS, Verniaud WM, Melnick JL, Rawls WE (1970). The early growth and development of infants with congenital rubella. Adv Teratol 4: 39–63.Google Scholar
  24. Deykin EY, MacMahon B (1979). Viral exposure and autism. Am J Epidemiol 109: 628–638.PubMedGoogle Scholar
  25. Enbom M (2001). Human herpesvirus 6 in the pathogenesis of multiple sclerosis. APMIS 109: 401–411.PubMedCrossRefGoogle Scholar
  26. Fombonne E (1989). Season of birth and childhood psychosis. Br J Psychiatry 155: 655–661.PubMedGoogle Scholar
  27. Fombonne E (1999). The epidemiology of autism: a review. Psychol Med 29: 769–786.PubMedCrossRefGoogle Scholar
  28. Fombonne E, Chakrabarti S (2001). No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics 108: E58.PubMedCrossRefGoogle Scholar
  29. Fotheringham JB (1991). Autism: its primary psychological and neurological deficit. Can J Psychiatry 36: 686–692.PubMedGoogle Scholar
  30. Fujinami RS, Libbey JE (1999). Endogenous retroviruses: are they the cause of multiple sclerosis? Trends Microbiol 7: 263–264.PubMedCrossRefGoogle Scholar
  31. Geeraedts F, Wilczak N, van Binnendijk R, De Keyser J (2004). Search for morbillivirus proteins in multiple sclerosis brain tissue. Neuroreport 15: 27–32.PubMedCrossRefGoogle Scholar
  32. Ghaziuddin M, Tsai LY, Eilers L, Ghaziuddin N (1992). Brief report: autism and herpes simplex encephalitis. J Autism Dev Disord 22: 107–113.PubMedCrossRefGoogle Scholar
  33. Ghosh S, Armitage E, Wilson D, Minor PD, Afzal MA (2001). Detection of persistent measles virus infection in Crohn’s disease: current status of experimental work. Gut 48: 748–752.PubMedCrossRefGoogle Scholar
  34. Gillberg C (1986). Onset at age 14 of a typical autistic syndrome. A case report of a girl with herpes simplex encephalitis. J Autism Dev Disord 16: 369–375.PubMedCrossRefGoogle Scholar
  35. Gillberg C (1990). Do children with autism have March birthdays? Acta Psychiatr Scand 82: 152–156.PubMedCrossRefGoogle Scholar
  36. Greer MK, Lyons-Crews M, Mauldin LB, Brown FR III (1989). A case study of the cognitive and behavioral deficits of temporal lobe damage in herpes simplex encephalitis. J Autism Dev Disord 19: 317–326.PubMedCrossRefGoogle Scholar
  37. Gregg NM (1941). Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust 3: 35–46.Google Scholar
  38. Gupta S, Rimland B, Shilling PD (1996). Pentoxifylline: brief review and rationale for its possible use in the treatment of autism. J Child Neurol 11: 501–504.PubMedCrossRefGoogle Scholar
  39. Haase AT, Ventura P, Gibbs CJ Jr, Tourtellotte WW (1981). Measles virus nucleotide sequences: detection by hybridization in situ. Science 212: 672–675.PubMedCrossRefGoogle Scholar
  40. Halsey NA, Hyman SL (2001). Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12—13, 2000. Pediatrics 107: E84.PubMedCrossRefGoogle Scholar
  41. Hanisch U-K, Seto D, Quirion R (1993). Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2. J Neurosci 13: 3368–3374.PubMedGoogle Scholar
  42. Hetzler BE, Griffin JL (1981). Infantile autism and the temporal lobe of the brain. J Autism Dev Disord 11: 317–330.PubMedCrossRefGoogle Scholar
  43. Hornig M, Weissenbock H, Horscroft N, Lipkin WI (1999). An infection-based model of neurodevelopmental damage. Proc Natl Acad Sci U S A 96: 12102–12107.PubMedCrossRefGoogle Scholar
  44. Ivarsson SA, Bjerre I, Vegfors P, Ahlfors K (1990). Autism as one of several disabilities in two children with congenital cytomegalovirus infection. Neuropediatrics 21: 102–103.PubMedCrossRefGoogle Scholar
  45. Johnson RT (1982). Viral infections of the developing nervous system. In: Viral infections of the nervous system, 2nd edition. New York: Lippincott-Raven Publishers; pp 203–236.Google Scholar
  46. Jorgensen OS, Goldschmidt VV, Vestergaard BF (1982). Herpes simplex virus (HSV) antibodies in child psychiatric patients and normal children. Acta Psychiatr Scand 66: 42–49.CrossRefGoogle Scholar
  47. Jyonouchi H, Sun S, Le H (2001). Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 120: 170–179.PubMedCrossRefGoogle Scholar
  48. Kawashima H, Mori T, Kashiwagi Y, Takekuma K, Hoshika A, Wakefield A (2000). Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Dig Dis Sci 45: 723–729.PubMedCrossRefGoogle Scholar
  49. Kaye JA, del Mar Melero-Montes M, Jick H (2001). Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ 322: 460–463.PubMedCrossRefGoogle Scholar
  50. Kemper TL, Bauman M (1998). Neuropathology of infantile autism. J Neuropathol Exp Neurol 57: 645–652.PubMedCrossRefGoogle Scholar
  51. Kim IJ, Beck HN, Lein PJ, Higgins D (2002). Interferon gamma induces retrograde dendritic retraction and inhibits synapse formation. J Neurosci 22: 4530–4539.PubMedGoogle Scholar
  52. Knobloch H, Pasamanick B (1975). Some etiologic and prognostic factors in early infantile autism and psychosis. Pediatrics 55: 182–191.PubMedGoogle Scholar
  53. Konstantareas MM, Hauser P, Lennox C, Homatidis S (1986). Season of birth in infantile autism. Child Psychiatry Hum Dev 17: 53–65.PubMedCrossRefGoogle Scholar
  54. Krause I, He XS, Gershwin ME, Shoenfeld Y (2002). Brief report: immune factors in autism: a critical review. J Autism Dev Disord 32: 337–345.PubMedCrossRefGoogle Scholar
  55. LaFerla FM, Sugarman MC, Lane TE, Leissring MA (2000). Regional hypomyelination and dysplasia in transgenic mice with astrocyte-directed expression of interferon-gamma. J Mol Neurosci 15: 45–59.PubMedCrossRefGoogle Scholar
  56. Landau EC, Cicchetti DV, Klin A, Volkmar FR (1999). Season of birth in autism: a fiction revisited. J Autism Dev Disord 29: 385–393.PubMedCrossRefGoogle Scholar
  57. Legaspi RC, Gatmaitan B, Bailey EJ, Lerner AM (1980). Interferon in biopsy and autopsy specimens of brain. Its presence in herpes simplex virus encephalitis. Arch Neurol 37: 76–79.PubMedGoogle Scholar
  58. Lotter V (1966). Epidemiology of autistic conditions in young children. I: Prevalence. Soc Psychiatry 1: 124–137.CrossRefGoogle Scholar
  59. Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M (2002). A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 347: 1477–1482.PubMedCrossRefGoogle Scholar
  60. Makela A, Nuorti JP, Peltola H (2002). Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics 110: 957–963.PubMedCrossRefGoogle Scholar
  61. Markowitz PI (1983). Autism in a child with congenital cytomegalovirus infection. J Autism Dev Disord 13: 249–253.PubMedCrossRefGoogle Scholar
  62. Martin WJ (1995). Stealth virus isolated from an autistic child. J Autism Dev Disord 25: 223–224.PubMedCrossRefGoogle Scholar
  63. Money J, Bobrow NA, Clarke FC (1971). Autism and autoimmune disease: a family study. J Autism Child Schizophr 1: 146–160.PubMedCrossRefGoogle Scholar
  64. Muñoz-Ferńandez MA, Fresno M (1998). The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol 56: 307–340.PubMedCrossRefGoogle Scholar
  65. Nelson KB (1991). Prenatal and perinatal factors in the etiology of autism. Pediatrics 87: 761–766.PubMedGoogle Scholar
  66. Oldstone MBA (1982). Immunopathology of persistent viral infections. Hosp Pract (Off Ed) 17: 61–72.Google Scholar
  67. Orange JS, Biron CA (1996). An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 156: 1138–1142.PubMedGoogle Scholar
  68. Patterson PH (2002). Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr Opin Neurobiol 12: 115–118.PubMedCrossRefGoogle Scholar
  69. Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M (1998). No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 351: 1327–1328.PubMedCrossRefGoogle Scholar
  70. Pletnikov MV, Rubin SA, Vasudevan K, Moran TH, Carbone KM (1999). Developmental brain injury associated with abnormal play behavior in neonatally Borna disease virus-infected Lewis rats: a model of autism. Behav Brain Res 100: 43–50.PubMedCrossRefGoogle Scholar
  71. Raymond GV, Bauman ML, Kemper TL (1996). Hippocampus in autism: a Golgi analysis. Acta Neuropathol (Berl) 91: 117–119.CrossRefGoogle Scholar
  72. Ring A, Barak Y, Ticher A, Ashkenazi I, Elizur A, Weizman A (1997). Evidence for an infectious etiology in autism. Pathophysiology 4: 91–96.CrossRefGoogle Scholar
  73. Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, Hallmayer J, Kalaydjieva L, McCague P, Dimiceli S, Pitts T, Nguyen L, Yang J, Harper C, Thorpe D, Vermeer S, Young H, Hebert J, Lin A, Ferguson J, Chiotti C, Wiese-Slater S, Rogers T, Salmon B, Nicholas P, Myers RM (1999). A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet 65: 493–507.PubMedCrossRefGoogle Scholar
  74. Ritvo ER, Freeman BJ, Scheibel AB, Duong T, Robinson H, Guthrie D, Ritvo A (1986). Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC Autopsy Research Report. Am J Psychiatry 143: 862–866.PubMedGoogle Scholar
  75. Rogers T, Kalaydjieva L, Hallmayer J, Petersen PB, Nicholas P, Pingree C, McMahon WM, Spiker D, Lotspeich L, Kraemer H, McCague P, Dimiceli S, Nouri N, Peachy T, Yang J, Hinds D, Risch N, Myers RM (1999). Exclusion of linkage to the HLA region in ninety multiplex sibships with autism. J Autism DevDisord 29: 195–201.CrossRefGoogle Scholar
  76. Rosenberger PB (1975). Editorial: infectious disease and the immature brain. N Engl J Med 293: 39–40.PubMedCrossRefGoogle Scholar
  77. Salazar-Mather TP, Hamilton TA, Biron CA (2000). A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J Clin Invest 105: 985–993.PubMedCrossRefGoogle Scholar
  78. Sargent IL (1993). Maternal and fetal immune responses during pregnancy. Exp Clin Immunogenet 10: 85–102.PubMedGoogle Scholar
  79. Sells CJ, Carpenter RL, Ray CG (1975). Sequelae of central-nervous-system enterovirus infections. N Engl J Med 293: 1–4.PubMedCrossRefGoogle Scholar
  80. Shi L, Fatemi SH, Sidwell RW, Patterson PH (2003). Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 23: 297–302.PubMedGoogle Scholar
  81. Singh VK, Jensen RL (2003). Elevated levels of measles antibodies in children with autism. Pediatr Neurol 28: 292–294.PubMedCrossRefGoogle Scholar
  82. Singh VK, Lin SX, Newell E, Nelson C (2002). Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism. J Biomed Sci 9: 359–364.PubMedCrossRefGoogle Scholar
  83. Singh VK, Lin SX, Yang VC (1998). Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin Immunol Immunopathol 89: 105–108.PubMedCrossRefGoogle Scholar
  84. Sola P, Merelli E, Marasca R, Poggi M, Luppi M, Montorsi M, Torelli G (1993). Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. J Neurol Neurosurg Psychiatry 56: 917–919.PubMedCrossRefGoogle Scholar
  85. Steffenburg S, Gillberg C, Hellgren L, Andersson L, Gillberg IC, Jakobsson G, Bohman M (1989). A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry 30: 405–416.PubMedCrossRefGoogle Scholar
  86. Stubbs EG (1976). Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination. J Autism Child Schizophr 6: 269–274.PubMedCrossRefGoogle Scholar
  87. Stubbs EG (1978). Autistic symptoms in a child with congenital cytomegalovirus infection. J Autism Child Schizophr 8: 37–43.PubMedCrossRefGoogle Scholar
  88. Stubbs G (1995). Interferonemia and autism. J Autism Dev Disord 25: 71–73.PubMedCrossRefGoogle Scholar
  89. Sumaya CV, Myers LW, Ellison GW, Ench Y (1985). Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. Ann Neurol 17: 371–377.PubMedCrossRefGoogle Scholar
  90. Sweeten TL, Bowyer SL, Posey DJ, Halberstadt GM, McDougle CJ (2003a). Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 112: e420.PubMedCrossRefGoogle Scholar
  91. Sweeten TL, Posey DJ, McDougle CJ (2003b). High blood monocyte counts and neopterin levels in children with autistic disorder. Am J Psychiatry 160: 1691–1693.PubMedCrossRefGoogle Scholar
  92. Sweeten TL, Posey DJ, McDougle CJ (2004a). Autistic disorder in three children with cytomegalovirus infection. J Autism Dev Disord 34: 583–586.PubMedCrossRefGoogle Scholar
  93. Sweeten TL, Posey DJ, Shankar S, McDougle CJ (2004b). High nitric oxide production in autistic disorder: a possible role for interferon-γ. Biol Psychiatry 55: 434–437.PubMedCrossRefGoogle Scholar
  94. Sweeten TL, Posey DJ, Shekhar A, McDougle CJ (2002). The amygdala and related structures in the pathophysiology of autism. Pharmacol Biochem Behav 71: 449–455.PubMedCrossRefGoogle Scholar
  95. Tanoue Y, Oda S, Asano F, Kawashima K (1988). Epidemiology of infantile autism in southern Ibaraki, Japan: differences in prevalence in birth cohorts. J Autism Dev Disord 18: 155–166.PubMedCrossRefGoogle Scholar
  96. Taylor B, Miller E, Farrington CP, Petropoulos MC, Favot-Mayaud I, Li J, Waight PA (1999). Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 353: 2026–2029.PubMedCrossRefGoogle Scholar
  97. Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J (2002). Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ 324: 393–396.PubMedCrossRefGoogle Scholar
  98. Thio CL, Thomas DL, Karacki P, Gao X, Marti D, Kaslow RA, Goedert JJ, Hilgartner M, Strathdee SA, Duggal P, O’Brien SJ, Astemborski J, Carrington M (2003). Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 77: 12083–12087.PubMedCrossRefGoogle Scholar
  99. Ticher A, Ring A, Barak Y, Elizur A, Weizman A (1996). Circannual pattern of autistic births: reanalysis in three ethnic groups. Hum Biol 68: 585–592.PubMedGoogle Scholar
  100. Torres AR, Maciulis A, Stubbs EG, Cutler A, Odell D (2002). The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder. Hum Immunol 63: 311–316.PubMedCrossRefGoogle Scholar
  101. Treffert DA (1970). Epidemiology of infantile autism. Arch Gen Psychiatry 22: 431–438.PubMedGoogle Scholar
  102. Tsunoda I, Fujinami RS (1999). Theiler’s murine encephalomyelitis virus. In: Persistent viral infections. Ahmed R, Chen I (eds). Chichester: John Wiley & Sons, pp 517–536.Google Scholar
  103. Tuchman RF, Rapin I (1997). Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. Pediatrics 99: 560–566.PubMedCrossRefGoogle Scholar
  104. Uhlmann V, Martin CM, Sheils O, Pilkington L, Silva I, Killalea A, Murch SB, Wakefield AJ, O’Leary JJ (2002). Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol 55: 84–90.PubMedCrossRefGoogle Scholar
  105. van Gent T, Heijnen CJ, Treffers PD (1997). Autism and the immune system. J Child Psychol Psychiatry 38: 337–349.PubMedCrossRefGoogle Scholar
  106. Wakefield AJ, Montgomery SM (1999). Autism, viral infection and measles-mumps-rubella vaccination. Isr Med Assoc J 1: 183–187.PubMedGoogle Scholar
  107. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351: 637–641.PubMedCrossRefGoogle Scholar
  108. Wakefield AJ, Pittilo RM, Sim R, Cosby SL, Stephenson JR, Dhillon AP, Pounder RE (1993). Evidence of persistent measles virus infection in Crohn’s disease. J Med Virol 39: 345–353.PubMedCrossRefGoogle Scholar
  109. Warren RP, Cole P, Odell JD, Pingree CB, Warren WL, White E, Yonk J, Singh VK (1990). Detection of maternal antibodies in infantile autism. J Am Acad Child Adolesc Psychiatry 29: 873–877.PubMedCrossRefGoogle Scholar
  110. Warren RP, Odell JD, Warren WL, Burger RA, Maciulis A, Daniels WW, Torres AR (1996). Strong association of the third hypervariable region of HLA-DR β1 with autism. J Neuroimmunol 67: 97–102.PubMedCrossRefGoogle Scholar
  111. Weinberg ED (1984). Pregnancy-associated depression of cell-mediated immunity. Rev Infect Dis 6: 814–831.PubMedGoogle Scholar
  112. Wong FS, Wen L (2003). The study of HLA class II and autoimmune diabetes. Curr Mol Med 3: 1–15.PubMedCrossRefGoogle Scholar
  113. Wong K (2001). The search for autism’s roots. Nature 411: 882–884.PubMedCrossRefGoogle Scholar
  114. Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C (2003). Prevalence of autism in a US metropolitan area. JAMA 289: 49–55.PubMedCrossRefGoogle Scholar
  115. Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H, Greenberg AH (1994). Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res 643: 40–49.PubMedCrossRefGoogle Scholar

Copyright information

© Journal of NeuroVirology, Inc. 2005

Authors and Affiliations

  • Jane E. Libbey
    • 1
  • Thayne L. Sweeten
    • 1
  • William M. McMahon
    • 2
  • Robert S. Fujinami
    • 1
  1. 1.Department of NeurologyUniversity of UtahSalt Lake CityUSA
  2. 2.Department of PsychiatryUniversity of UtahSalt Lake CityUSA

Personalised recommendations